SUBSCRIBE
SUBSCRIBE

Alloy Therapeutics

NEWS
Business
Newly-Launched Normunity Becomes Alloy’s Latest Partner in IO Deal
Alloy Therapeutics inked an antibody discovery deal with Normunity Thursday to advance the latter’s immune normalizers, antibody therapies that boost the body’s natural immune system to fight cancer.
November 17, 2022
 · 
1 min read
 · 
Rosemary Scott
male hands with wrist watch is considered American dollars. Hands holding dollar cash. 1000 dollars in 100 bills in a man's hand close-up on a dark background. hundred
Business
Money on the Move: EnPlusOne, Cellarity, Voyager and More
Funding rounds this week saw money flow into innovative drug discovery and delivery platforms, while pharma powerhouse Pfizer wrapped up two high-value neuro deals.
October 5, 2022
 · 
5 min read
 · 
Tristan Manalac
JOBS
IN THE PRESS
Business
Alloy Therapeutics Announces Platform License Agreement with Lilly
May 21, 2024
 · 
2 min read
Genetown
Alloy Therapeutics and Wheeler Bio Announce Preferred Service Offering for Alloy Partners to Accelerate the Translation from Discovery to CMC
November 8, 2023
 · 
7 min read
Business
Alloy Therapeutics Announces Scientific Advisory Board to Drive Roadmap of Biotherapeutic Discovery Platform Innovation
September 20, 2023
 · 
5 min read
Business
Alloy Therapeutics Expands Executive Team to Strengthen Therapeutic Discovery and Innovation for Its Partners
June 29, 2023
 · 
4 min read
Genetown
Alloy Therapeutics Launches Proprietary AntiClastic™ Antisense Oligonucleotide Platform to Make Potent Genetic Medicines
June 28, 2023
 · 
6 min read
Business
Alloy Therapeutics to Empower Drug Discovery of Lundbeck’s Biologics for Brain Health
May 2, 2023
 · 
4 min read
Business
Alloy Therapeutics Announces an Expansion of its Antibody Discovery Services in Conjunction with Two New Senior Vice Presidents
April 26, 2023
 · 
5 min read
Genetown
Alloy Therapeutics Unveils 2023 Innovation Roadmap Across Antibodies, TCRs, Bispecifics, and Genetic Medicines
January 9, 2023
 · 
6 min read
Genetown
Alloy Therapeutics and Normunity Sign Multi-Program Antibody Discovery Collaboration in Immuno-Oncology
November 17, 2022
 · 
4 min read
Genetown
Alloy Therapeutics Raises $42 Million Series D Financing to Accelerate Discovery Technology Development Across Biologic Modalities
October 3, 2022
 · 
7 min read
Load More